-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Aytu Biopharma, Inc quarterly Deferred Tax Assets, Gross history and growth rate from Q2 2015 to Q2 2024.
- Aytu Biopharma, Inc Deferred Tax Assets, Gross for the quarter ending June 30, 2024 was $138M, a 0.5% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)